Yahoo Finanza Big Money Buying Up AbbVie
So, what’s Big Money? Said simply, that’s when a stock goes up in price alongside chunky volumes. It’s indicative of institutions betting on the shares.
Smart money managers are always looking for the next hot stock. And AbbVie has many fundamental qualities that are attractive.
This sets up well for the stock going forward. But how the shares have been trading points to more upside. As I’ll show you, the Big Money has been consistent in the shares all year.
You see, fund managers are always looking to bet on the next outlier stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way.
That’s why I’ve learned how critical it is to gauge Big Money demand for shares. To show you what I mean, have a look at all the Big Money signals ABBV has made the last year.
The last few weeks have seen Big Money activity, too. Each green bar signals big trading volumes as the stock ramped in price:
Source: www.mapsignals.com
In 2021, the stock has attracted 13 Big Money buy signals. Generally speaking, recent green bars could mean more upside is ahead.
Now, let’s check out technical action grabbing my attention:
1-month outperformance vs. Health Care Select Sector SPDR Fund (+6.9% vs. XLV)
Outperformance is important for leading stocks.
Next, it’s a good idea to check under the hood. Meaning, I want to make sure the fundamental story is strong too. As you can see, AbbVie has been growing sales at a double-digit rate. Take a look:
3-year sales growth rate (+18.4%)
1-year earnings growth rate (+10.5%)
Source: FactSet
Marrying great fundamentals with technically superior stocks is a winning recipe over the long-term.
In fact, ABBV has been a top-rated stock at my research firm, MAPsignals, for years. That means the stock has buy pressure, strong technicals, and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.
ABBV has a lot of qualities that are attracting Big Money. And since 2015, it’s made this list 7 times, with its first appearance on 6/20/2017… and gaining 76.17% since. The blue bars below show the times that AbbVie was a top pick since 2015:
Source: www.mapsignals.com
It’s been a top stock in the healthcare sector according to the MAPsignals process. I wouldn’t be surprised if ABBV makes additional appearances in the years to come. Let’s tie this all together.
The Bottom Line
The AbbVie rally could have further to go. Big Money buying in the shares is signaling to take notice. Shares could be positioned for further upside. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a growth-oriented portfolio.
Disclosure: the author holds long positions in ABBV in personal and managed accounts at the time of publication.
Learn more about the MAPsignals process here.
Disclaimer
https://mapsignals.com/contact/
This article was originally posted on FX Empire
